arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Corbus Pharmaceuticals Holdings, Inc.

CRBP

$10.16 ▲ +0.45 (+4.63%) at close

14 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Corbus Pharmaceuticals Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $135.3M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -45.7% ↘

FCF / Share $-4.84 ↘

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-78.54M

↓ -95.3% —

FCF / Share Free cash flow per share

$-4.84

↓ -26.5% —

Long-Term Debt Long-term obligations

$17.89M

↓ -17.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	—	—	—	N/M	-77.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1070%)	-89.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1214%)	649.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8019%)	97.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1120%)	27.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+246%)	194.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2335%)	—	—	—	—
EPS Growth YoY (%)	-60.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2643.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	73.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-95.3% Weak ↓ Weak Declining Year-over-year change in net income	9.9% Fair ↓ Fair Declining Year-over-year change in net income	-5.3% Weak ↓ Weak Declining Year-over-year change in net income	7.2% Fair ↑ Fair Improving Year-over-year change in net income	59.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-55.7% Weak → Weak Stable Year-over-year change in net income	-28.3% Weak ↑ Weak Improving Year-over-year change in net income	-71.7% Weak ↑ Weak Improving Year-over-year change in net income	-62.1% Weak ↑ Weak Improving Year-over-year change in net income	-126.0% Weak ↑ Weak Improving Year-over-year change in net income	-248.4% Weak Weak Year-over-year change in net income	-321.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-26.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	54.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	7.4% Fair ↑ Fair Improving Year-over-year change in free cash flow	-2196.0% Weak Weak Year-over-year change in free cash flow	69.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	-43.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	17.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	166.4% Excellent Excellent Compound annual revenue growth over 3 years	95.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	-14.3% Weak Weak Compound annual revenue growth over 5 years	43.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	-213.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1522%)	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	-197.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1747%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	-134.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—
FCF / Net Income (x)	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-45.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-324.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-153.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-989.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-162.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-177.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-77.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	24.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-50.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-159.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-120.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-156.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-120.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-48.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-111.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-182.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-53.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	-28.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-288%)	—	-128.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-956%)	-66.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-540%)	-245.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1738%)	—	-202.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1448%)	-56.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-474%)	-224.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1595%)	-98.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-757%)	-43.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-389%)	33.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+125%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	-2.59x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-532%)	0.65x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+9%)	0.31x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-49%)	0.40x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-34%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	-27.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.83x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-109.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-5437.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2630.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6415.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3628.56x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-110.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-28.49M	$-17.20M	$4.17M	$4.59M	$-3.82M	$-67.40M	$-31.75M	$-41.75M	$-62.54M	$-14.99M	$-12.34M	$-6.26M	$-303.02K	$-542.48K
Debt / EBITDA (x)	—	—	-0.40x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.39x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	—	—	—	$0.00	$0.01	$0.05	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-5.90	$-3.68	$-10.31	$-10.15	$-0.37	$-1.42	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-4.84	$-3.83	$-8.34	$-9.01	$-0.39	$-1.28	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$8.38	$11.69	$-1.56	$7.91	$0.55	$0.46	$0.10	$0.48	$1.04	$0.20	$0.24	$0.23	$-0.26	—
Tangible Book Value per Share (USD)	$8.38	$11.69	$-1.56	$7.91	$0.55	$0.46	$0.10	$0.48	$1.04	$0.20	$0.24	$0.23	$-0.26	—
Basic Weighted Avg Shares (shares)	13.32M	10.92M	4.33M	4.17M	122.99M	78.13M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$146.26M	$141.16M	$-8.35M	$47.54M	$83.20M	$60.18M	$3.27M	$26.15M	$57.30M	$8.50M	$9.08M	$5.79M	$-343.35K	—
LT Debt (USD)	—	—	$17.89M	$21.59M	$21.19M	$18.03M	—	—	—	—	—	—	—	—
Total Equity (USD)	$147.50M	$142.43M	$-6.90M	$32.99M	$69.11M	$45.27M	$6.16M	$27.52M	$57.78M	$8.92M	$8.99M	$5.86M	$-1.78M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$0.00	$881.71K	$3.94M	$36.14M	$4.82M	$2.44M	$1.91M	$648.38K	—	—	—
Depreciation Expense (USD)	$200.00K	$600.00K	$641.00K	$763.00K	$1.00M	$1.12M	$739.00K	—	—	—	$44.00K	$10.40K	—	—
Net Income, GAAP (USD)	$-78.54M	$-40.21M	$-44.60M	$-42.35M	$-45.64M	$-111.27M	$-71.45M	$-55.67M	$-32.42M	$-20.00M	$-8.85M	$-2.54M	$-602.35K	—
Operating Cash Flow (USD)	$-64.49M	$-41.79M	$-36.10M	$-37.54M	$-48.18M	$-99.69M	$-45.72M	$-30.07M	$-27.80M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 53 quarters

Corbus Pharmaceuticals Holdings, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRBP with peers